Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

CELLTRION USA, Inc.

NDC labeler code: 72606

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

18Products (NDC)

Prescription medicines

FDA applications for these products

  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
January 21, 2026BLA761498 Tocilizumab
AVTOZMA
Celltrion Inc
March 7, 2025BLA761399 Omalizumab
OMLYCLO
Celltrion Inc
February 28, 2025BLA761404 Denosumab
OSENVELT, STOBOCLO
Celltrion Inc
January 24, 2025BLA761420 Tocilizumab
AVTOZMA
Celltrion Inc
December 17, 2024BLA761338 Ustekinumab
STEQEYMA
Celltrion, Inc.
October 20, 2023BLA761358 Infliximab-dyyb
ZYMFENTRA
Celltrion
September 27, 2022BLA761268 Bevacizumab
VEGZELMA
Celltrion

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

No recall of these products (by NDC code) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →